MYC and cancer: Similarly potent alterations in cancer-associated genes, e.g., MYC amplification (neuroblastoma), SMARCB1 deletion (malignant rhaboid tumor), BRD4-NUT fusion and EWSR1 fusions also profoundly affect gene expression.